If you’re a Medicare beneficiary in Washington State wondering whether your plan covers Ozempic — you’re not alone. This is one of the most common questions I hear from clients right now, and the answer is more nuanced than a simple yes or no.
Ozempic (semaglutide) is a GLP-1 receptor agonist originally approved for Type 2 diabetes management. It’s also the same drug class as Wegovy, which is FDA-approved specifically for weight loss. Whether Medicare covers Ozempic in 2026 depends on why it’s being prescribed, which Medicare plan you’re enrolled in, and the specific formulary your plan uses — details that vary significantly across Washington State plans.
As a licensed Washington State health insurance broker with over a decade helping Medicare beneficiaries in this state navigate exactly these kinds of questions, I want to give you a straight answer — not a marketing pitch. Let’s break this down clearly.
Ozempic is a once-weekly injectable medication manufactured by Novo Nordisk. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking a hormone that regulates blood sugar and appetite. It was FDA-approved for Type 2 diabetes, and physicians frequently prescribe it off-label for weight management as well.
Here’s where Medicare coverage gets complicated:
This distinction — diabetes drug vs. weight loss drug — is the single most important factor in determining whether your Medicare plan in Washington State will cover Ozempic.
There has been growing pressure on CMS (Centers for Medicare & Medicaid Services) to expand GLP-1 drug coverage for Medicare beneficiaries. In 2025, CMS signaled it would allow Medicare Part D and Medicare Advantage plans to optionally cover GLP-1 medications approved for cardiovascular risk reduction — which includes semaglutide. However, this is optional for plans, not mandated.
What this means for Washington State Medicare beneficiaries in 2026:
For a full overview of how Medicare Parts A, B, C, and D work together in Washington, see our guide: Medicare Parts A, B, C & D in Washington State Explained.
Medicare Part D is your outpatient prescription drug coverage. It’s available either as a stand-alone Part D plan (if you have Original Medicare) or as part of a Medicare Advantage plan that bundles drug coverage (called MAPD plans).
Whether Part D covers Ozempic comes down to three things: the plan’s formulary, the drug tier assignment, and your diagnosis documentation.
Each Medicare Part D plan maintains a formulary — a list of covered drugs. Formularies change annually, which is exactly why comparing your plan options during the Annual Enrollment Period (AEP, October 15 – December 7) matters so much.
For 2026, here’s what Washington State beneficiaries should know:
This is where many people get caught off guard. Traditional Medicare law under the Social Security Act has long excluded coverage of drugs used “for weight loss.” Because of this, if Ozempic is prescribed solely for weight management — and not tied to a diabetes or cardiovascular diagnosis — Part D plans are not permitted to cover it under standard rules.
However, the Inflation Reduction Act and subsequent CMS guidance opened a narrow door: plans may cover semaglutide when it’s prescribed for cardiovascular risk reduction in patients who already have established cardiovascular disease. A select number of plans in Washington have exercised this option in 2026 — but it is far from universal.
The bottom line: diagnosis matters. If you have Type 2 diabetes or qualifying cardiovascular disease, your chances of Part D coverage are meaningfully better than if your prescription is based on weight loss alone.
Even when a Washington State Part D plan does cover Ozempic, beneficiaries should understand the cost reality:
If managing prescription drug costs across all your medications is a concern — and for most Medicare beneficiaries it is — this is exactly the kind of plan comparison that a licensed Washington broker can run for you at no cost to you.
Medicare Advantage (Part C) plans are offered by private insurance companies approved by Medicare. In Washington State, there are multiple Medicare Advantage plans available depending on your county — and their Ozempic coverage varies considerably.
Unlike stand-alone Part D plans, Medicare Advantage plans with drug coverage (MAPD) have more flexibility in how they structure their formularies, and some have been more aggressive than others in adding GLP-1 drugs as an enrolled benefit in 2026.
When evaluating whether a Medicare Advantage plan in Washington covers Ozempic, ask these specific questions:
Washington State has a range of Medicare Advantage options — including HMO and PPO structures — and plan availability varies by ZIP code. Our dedicated page walks through Medicare Advantage Plans in Washington State in detail, including how to compare your county-specific options.
If you’re enrolled in Original Medicare (Parts A and B) with a Medicare Supplement (Medigap) plan, it’s important to understand what Medigap does and doesn’t do. Medigap plans in Washington State help pay for the gaps in Original Medicare — things like hospital copays and Part B coinsurance. They do not provide prescription drug coverage.
If you’re on an Original Medicare + Medigap combination, you would need a separate stand-alone Part D plan to have any prescription drug coverage, including any potential Ozempic coverage.
For Washington State residents exploring Medigap options alongside drug coverage, our Washington Medicare Plan Options for 2026 guide covers the full landscape of choices available this year.
The honest truth from a Washington broker: Ozempic coverage under Medicare in 2026 is real — but it’s not automatic, and it’s not the same across every plan. The difference between a plan that covers it and one that doesn’t can mean thousands of dollars a year out of your pocket. This is exactly the kind of comparison that takes five minutes with the right broker and potentially saves you significant money.
— Kevin Husted, Founder, Advisor Health Benefits Group | Licensed Washington State Health Insurance Broker
Washington Medicare Resources
Each guide below is written for Washington State Medicare beneficiaries. No national generalities — just the rules, plans, and options that apply to you in 2026.
The full landscape of Medicare options available in Washington State — Original Medicare, Advantage, Supplement, and Part D — explained side by side.
Read the guide Medicare AdvantageHow HMO and PPO Advantage plans work in Washington, what counties they cover, and how to compare your options — including drug formularies.
Read the guide Medicare basicsA plain-English breakdown of what each Medicare part covers, what it costs, and how they fit together for Washington State beneficiaries.
Read the guide 2026 UpdateWhat changed for Washington Medicare beneficiaries this year — premiums, deductibles, out-of-pocket caps, and formulary shifts worth knowing about.
Read the guide Prior authorizationNew CMS rules, timeline protections, and what Washington beneficiaries can do when a plan delays or denies a drug or procedure authorization.
Read the guide Medicaid & dual-eligibleHow Washington Apple Health and Medicare intersect for dual-eligible beneficiaries — including Extra Help, D-SNPs, and 2026 asset limit updates.
Read the guideFree Plan Review — No Cost, No Obligation
A 15-minute conversation with a licensed Washington broker can tell you exactly which plans in your county cover Ozempic — and what your real out-of-pocket cost will be. No pressure, no catch. Broker service is free to you.
Knowing the general rules is one thing. Knowing what your specific plan does right now is what actually saves you money. This section gives you the exact steps to check your coverage, the levers you can pull if your plan denies coverage, and the Washington-specific options worth knowing about in 2026.
I walk clients through this process regularly. It’s not complicated once you know where to look — but it does require going beyond the plan’s marketing materials and digging into the actual formulary documents.
Every Medicare Part D and Medicare Advantage plan is required to publish its formulary — the complete list of covered drugs — on its website and in its Annual Notice of Change documents. This is your starting point.
Here’s how to find it:
Even when a plan lists semaglutide on its formulary, coverage is almost always conditioned on diagnosis. Your prescribing physician will need to document one of the following in your medical record and in any prior authorization request:
Your doctor’s office should be familiar with this process, but it doesn’t hurt to call ahead and confirm they’re prepared to submit the prior authorization with the right diagnosis codes. A denied prior auth due to incomplete documentation is one of the most avoidable coverage problems I see.
For a detailed look at how prior authorization works under Washington Medicare plans in 2026 — including new CMS rules that limit how long plans can delay decisions — read our article on Medicare Prior Authorization in Washington 2026.
If your plan doesn’t cover Ozempic on its standard formulary, you’re not necessarily out of options. Medicare rules give beneficiaries the right to request a formulary exception — a formal appeal asking the plan to cover a drug that isn’t on its formulary (or to cover it at a lower cost tier).
To have a realistic shot at a formulary exception for Ozempic, your doctor needs to submit a statement of medical necessity explaining:
Plans are required to respond to standard exception requests within 72 hours, and within 24 hours for expedited requests when a delay could seriously harm your health. If the plan denies the exception, you have the right to appeal through Medicare’s formal appeals process — a right that Washington State beneficiaries should understand and not be afraid to use.
A coverage denial for Ozempic is frustrating, but it’s not the end of the road. Here are the concrete options available to Washington State Medicare beneficiaries in 2026.
The most powerful tool you have is plan choice. If your current Medicare plan doesn’t cover Ozempic — and this drug is important to your health management — the right answer may simply be to enroll in a plan that does.
In Washington State, enrollment windows that allow plan changes include:
Plan formularies change every year, which is why a plan comparison at each AEP isn’t optional — it’s essential. A plan that covered Ozempic in 2025 may have removed it in 2026, or vice versa. This is the kind of annual review I do with every Medicare client I work with in Washington State.
See the full breakdown of plan options currently available in our state: Washington Medicare Plan Options for 2026.
If your plan does cover Ozempic but the cost-sharing is unmanageable, the Medicare Extra Help program — also called the Low Income Subsidy (LIS) — can dramatically reduce what you pay for Part D drugs, including GLP-1 medications.
In 2026, qualifying Washington State residents with Extra Help pay significantly reduced premiums, deductibles, and copays for covered Part D drugs. The income and asset thresholds are higher than many people expect — it’s worth checking even if you don’t think you qualify.
Extra Help eligibility is also closely tied to Washington Apple Health (Medicaid) enrollment status. Our guide on Washington Medicare & Medicaid Changes for 2026 covers how these programs interact and what changed this year for dual-eligible beneficiaries.
Washington State residents who qualify for both Medicare and Medicaid — known as dual-eligible beneficiaries — may have access to Ozempic coverage through Washington Apple Health that isn’t available through their Medicare plan alone.
Washington Apple Health’s Preferred Drug List (PDL) includes semaglutide for qualifying diabetes diagnoses, and the state’s managed care plans that serve dual-eligible members have more flexibility in formulary coverage than standard Medicare plans. If you or someone you’re helping is dual-eligible, this is an important avenue to explore.
If you’re navigating a transition from Apple Health to Medicare, our dedicated resource on Washington Apple Health Transitions walks through how to protect your coverage during that process.
This option applies specifically to Washington State Medicare beneficiaries who do not qualify for Extra Help and whose plan does not cover Ozempic. Novo Nordisk, the manufacturer of Ozempic, offers a patient assistance program — NovoCare — that may provide the medication at reduced or no cost for qualifying patients.
Eligibility requirements apply, and these programs change periodically. Your physician’s office or a licensed broker can point you toward the current application process. This isn’t a Medicare benefit — it’s a manufacturer program — but it’s a legitimate bridge while you evaluate plan options.
Even when Ozempic is on your plan’s formulary, prior authorization is nearly universal for GLP-1 medications in 2026. This isn’t unique to Washington — it’s a national pattern — but the timelines and processes vary plan to plan, and delays can leave patients without medication.
Here’s what the prior authorization process for Ozempic typically looks like under Washington Medicare plans:
Washington Medicare beneficiaries have stronger protections in 2026 around prior authorization timelines. Under rules finalized by CMS, Medicare Advantage plans must:
These are meaningful protections. If your plan violates these timelines, you have the right to file a complaint with Medicare directly. Our prior authorization article covers this in more detail: Medicare Prior Authorization Changes in Washington 2026.
Many Washington Medicare plans that do cover Ozempic impose step therapy — meaning they require you to try and demonstrate failure on one or more alternative medications before they’ll approve coverage for Ozempic.
Common step therapy requirements for Ozempic in 2026 include trying:
If you’ve already been on one of these medications and it was ineffective or caused adverse effects, document this clearly with your doctor. Prior documented treatment failure is the strongest argument for bypassing step therapy and going directly to Ozempic coverage. Your physician can submit this history as part of the prior authorization to significantly strengthen the approval case.
What I tell my Washington clients: Don’t accept a coverage denial as a final answer — and don’t try to navigate the appeals process alone. Prior authorizations, formulary exceptions, and plan comparisons are exactly the kind of thing a licensed broker handles as part of your service relationship, at no cost to you. Medicare’s rules are designed to give you options. The key is knowing which ones apply to your situation.
— Kevin Husted, Founder, Advisor Health Benefits Group | Licensed Washington State Health Insurance Broker
By now you understand the rules. You know that coverage depends on your diagnosis, your plan’s formulary, and the specific way your plan has implemented CMS’s 2026 guidance on GLP-1 medications. What you may still be wondering is: which plans in Washington State actually cover this drug, and how do I find the right one for my situation?
This section answers that — and explains why working with a licensed local broker isn’t just convenient, it’s the most reliable way to get this right.
Washington State has a competitive Medicare market. Depending on your county, you may have access to a dozen or more Medicare Advantage plans, several stand-alone Part D options, and the full range of Medicare Supplement (Medigap) plans. Their approach to Ozempic coverage in 2026 is not uniform.
Medicare Advantage plans have the broadest discretion in formulary design, and in 2026 that variability is especially pronounced for GLP-1 drugs. Washington State Medicare Advantage carriers that operate HMO and PPO plans in counties like King, Pierce, Snohomish, Spokane, and Clark have each made independent formulary decisions about semaglutide.
General patterns I’ve observed across Washington Medicare Advantage plans in 2026:
The right Medicare Advantage plan for you is not necessarily the one with the lowest premium — it’s the one whose formulary, network, and total out-of-pocket structure fits your actual prescriptions and your doctors. Our full guide to Medicare Advantage Plans in Washington State walks through how to evaluate these tradeoffs county by county.
If you’re on Original Medicare with a Medigap plan, you pair it with a stand-alone Part D plan for drug coverage. In Washington State, the Part D market includes plans from several national carriers, and their Ozempic formulary positions differ meaningfully.
When comparing stand-alone Part D plans for Ozempic coverage in Washington, the key variables to compare side by side are:
That last point is critical. A plan that covers Ozempic at a lower tier but charges more for your other medications may cost you more overall than a plan that requires a higher Ozempic copay but covers everything else more efficiently. This is a calculation that requires running the numbers across your complete medication list — something Medicare Plan Finder can do, and that a broker can do faster with more context about your situation.
Washington State Medigap plans — Plan G, Plan N, and the other standardized supplement options — do not cover prescription drugs. They never have. Their value is in eliminating the unpredictable out-of-pocket costs that come with Original Medicare’s hospital and medical coverage.
However, Washington State has its own Medigap rules that differ from federal minimums in a few important ways — including guaranteed issue protections that are stronger than most other states. If Ozempic coverage is a priority and you want the freedom to see any Medicare-accepting provider in Washington (which Original Medicare + Medigap provides), the right strategy is pairing a Medigap plan with a carefully chosen Part D plan that covers your prescriptions well.
For a current comparison of Washington Medigap options alongside Medicare Advantage: Washington Medicare Plan Options for 2026.
Here are the questions I ask every Washington Medicare client who is on Ozempic or anticipates needing it:
This determines which formulary pathways are open to you. Type 2 diabetes opens the most doors. Established ASCVD opens a second set. Weight loss alone, without a documented comorbidity, is the most restricted pathway in 2026.
Network access matters as much as formulary. An HMO plan that covers Ozempic but doesn’t include your endocrinologist may not actually serve you well. PPO plans offer more flexibility but typically at higher cost.
Optimizing for one drug while ignoring the rest of your medication list is how people end up surprised at the pharmacy counter in February. The right plan covers your complete medication profile efficiently.
Medicare Advantage plan availability in Washington State is county-specific. The plans available in Spokane County are not the same as those available in King County, and rural counties often have fewer options. Your ZIP code matters.
If you’re managing diabetes with Ozempic, you likely have regular labs, specialist visits, and possibly ophthalmology or podiatry needs. Your plan’s cost structure for these services affects your total cost of care — not just the drug itself.
National Medicare comparison websites can show you formulary data. Medicare.gov’s Plan Finder is a legitimate and useful tool. But neither of those resources knows the Washington State insurance market the way a broker who has worked in it for years does.
Here is what a licensed local Washington broker brings to this process that a website cannot:
This is the service Advisor Health Benefits Group provides to Washington State Medicare beneficiaries. It’s what I built this practice to do.
If you’ve read this far, you’re ready to take action. Here is the straightforward path forward depending on your current situation:
No. There is no automatic coverage. Whether Medicare covers Ozempic depends on your specific plan’s formulary, your diagnosis, and whether prior authorization is approved. Original Medicare (Parts A and B) alone never covers Ozempic — you need Part D or a Medicare Advantage plan with drug coverage.
In most cases, no. Medicare has historically been prohibited from covering weight loss drugs. In 2026, a narrow exception exists for plans that have opted to cover semaglutide for cardiovascular risk reduction — but this requires a documented ASCVD diagnosis, not just a desire to lose weight. If weight management is your primary goal without a qualifying comorbidity, coverage under Medicare remains extremely limited.
When covered, Ozempic typically falls on Tier 3 or Tier 4 of a Part D formulary. Actual cost-sharing varies by plan, but beneficiaries can expect meaningful copays or coinsurance until they reach their out-of-pocket threshold. The 2026 Part D out-of-pocket cap of $2,000 provides a ceiling — but reaching it requires significant spending first. Medicare Extra Help can substantially reduce these costs for qualifying Washington beneficiaries.
Wegovy (higher-dose semaglutide, FDA-approved specifically for chronic weight management) faces the same coverage limitations as Ozempic when prescribed for weight loss. Some plans have extended optional coverage for Wegovy under the cardiovascular risk indication — but this is plan-specific and not widespread in 2026. Check your plan’s formulary specifically for semaglutide 2.4mg (Wegovy’s dosage) separately from Ozempic.
Yes — if the drug is not on the formulary or prior authorization is denied, the plan can decline to cover it. However, you have the right to request a formulary exception and to appeal any denial through Medicare’s formal appeals process. A licensed broker or a State Health Insurance Assistance Program (SHIP) counselor in Washington can help you navigate that process at no cost.
Medicare plan selection in 2026 is not a decision that benefits from guesswork. Whether Ozempic coverage is your primary concern or one of several factors you’re weighing, getting an independent, comprehensive plan comparison takes less time than you think — and costs you nothing.
Advisor Health Benefits Group is a Washington State licensed independent health insurance agency. I work with Medicare beneficiaries across Washington — from the Seattle metro to Eastern Washington — helping them find plans that actually fit their health situation and their budget. I’m not captive to any carrier. I compare every option available in your county and give you a straight answer.
If you have questions about Ozempic coverage, Medicare plan options, or anything else covered in this article, reach out directly. That’s what I’m here for.
Sources & Further Reading
Medicare Drug Coverage (Part D) — Medicare.gov medicare.gov/drug-coverage-part-d — Official CMS resource on how Part D works, what it covers, and how to compare plans in your area.
Medicare Plan Finder — Compare Washington State Plans medicare.gov/plan-compare — Search every Medicare Advantage and Part D plan available in your Washington ZIP code, including formulary drug lists and estimated costs.
Medicare Prior Authorization & Appeals Rights — CMS cms.gov — Medicare Advantage Prior Authorization Policy — CMS documentation on beneficiary rights, response timelines, and the 2024–2026 prior authorization rule changes.
Medicare Extra Help (Low Income Subsidy) — Social Security Administration ssa.gov/medicare/part-d-extra-help — Eligibility requirements, income and asset limits, and how to apply for Extra Help to reduce Part D drug costs in Washington State.
Washington Apple Health (Medicaid) — Washington State HCA hca.wa.gov — Apple Health Medicaid Coverage — Washington State Health Care Authority’s official resource on Apple Health eligibility, covered services, and managed care plans.
FDA — Ozempic & Wegovy Prescribing Information fda.gov — Ozempic (semaglutide) Drug Approval — FDA official approval record and prescribing information for semaglutide, including approved indications for Type 2 diabetes and cardiovascular risk reduction.
SHIP — Washington State Medicare Counseling (SHIBA) insurance.wa.gov — SHIBA Program — Washington State’s free Medicare counseling program offering unbiased help with plan selection, appeals, and billing issues.
